Stock Alerts on Thursday’s Market Movers: LUV, TIVO, JOSB, ADP
Wall Street took a downturn this morning as the markets reacted to GM’s announcement of more temporary factory shutdowns and weak economic data.
Wall Street took a downturn this morning as the markets reacted to GM’s announcement of more temporary factory shutdowns and weak economic data.
ZAP completes electric pickup engineering initiative, manufactured and built in the United States
Several stocks released news in today’s trading session, though most failed to secure positive trading amid broad-based decline on Wall Street.
Company's New Power Amplifier Technology Cuts Consumption up to 75%
After gaining ground in today’s early session, Wall Street retreated on report of increased layoffs in May. Today’s lineup had mixed results, with AGEN soaring 44% on data from its kidney cancer therapy.
Word of strategic partnerships, financial reports and other notable stories drove trading activity for stocks in today’s mixed session.
Technology stocks had mixed trading today as Wall Street seesawed on pending home sales, losses in the financial sector, and continued GM news.
Company's Acquired Working Interest is Located in Historically Gas-Rich Region; Company believes Natural Gas Prices will continue to Rise as Economy Heals
Notable headlines pushed several stocks into Monday's spotlight as data construction spending bolstered bullish sentiment.
Last week’s favorable durable goods orders report created a stir in transportation stocks; several railroad companies continued the climb in this morning’s early trading session.
General Motors electronically filed for Chapter 11 protection this morning, marking it the fourth-largest bankruptcy in U.S. history. GM, as well as several pharmaceutical companies is highlighted in this morning’s stock alerts. ADXS surged nearl ...
Allos Therapeutics announced results this weekend of the phase II PROPEL study of the its promising new anti-blood cancer drug pralatrexate. The development of pralatrexate is hoped to treat patients with a rare but aggressive form of blood canc ...
Menlo Park, Calif.-headquartered KANA Software, provider of award-winning solutions for mastering the multi-channel service experience, recently announced its financial results for the first quarter ended March 31, 2009.
Smart-card technology company On Track Innovations Posts Q1 increase in revenue and its highlights its introduction into Homeland Security issues.
After trading on mixed results in the early morning session, top pharmaceutical stocks dipped lower as Wall Street reacted to the government’s report that the economy slipped 5.7% in Q1.
Synovis posts a 60% increase in second-quarter profit and 19% increase in revenue; Thompson Reuter Analysts maintain Hold rating.
Company’s corrective optical laser surgery garners desirable results in first-stage animal trials; continued development and advancement lead the technology one step closer to FDA approval.
Company says initial phase of clinical validation trials of NuroPro® AD blood test shows successful diagnoses of different forms of Alzheimer's, including high-risk patients.
After jumping $5.85, or 186%, on Tuesday, and $3.93, or 43.67% yesterday, shares of Map Pharmaceuticals surged nearly 6% to $12.85 this morning, fueled by word of its migraine treatment, Levadex.
Revenue Up, Income Down; Cash Sharply Higher